article thumbnail

Leading pharmaceutical solid dose (commercial dose) manufacturing companies in contract marketing

Pharmaceutical Technology

Pharmaceutical solid dose manufacturing companies in contract marketing segment have gained a vital position in pharmaceutical formulations. Find the leading pharmaceutical solid dose manufacturing companies in contract marketing.

article thumbnail

How Are Biopharma Companies Evaluating Partnerships in the Rare Disease Space?

Camargo

Thomas Kassberg, Chief Business Officer, Ultragenyx. Often, only the first treatment available will make it to the market given the small patient populations, so it is important for developing partners to understand fully the natural history of disease progression, the indication, and the current standard of care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Merck confirms $11.5bn Acceleron takeover deal

pharmaphorum

The $180-per-share deal – if completed – will give Merck a pair of blockbuster drug candidates, one of which is already on the market, and help to reduce its reliance on $14.4 billion immuno-oncology blockbuster Keytruda (pembrolizumab).

Sales 117
article thumbnail

Why pharma isn’t yet achieving digital excellence, and how it can get there

pharmaphorum

Market pressures. Veeva highlights in the whitepaper that marketing and sales functions need to work closely together to deliver the right messages aligned with doctors’ real needs. Pharma needs to listen to what doctors are saying,” Noel says. Companies need to experiment with new ways of working and not be afraid to fail.

Sales 131
article thumbnail

VivoPlex raises funding to develop intra-uterine sensor

pharmaphorum

If the data support European approval, the sensor would be the company’s first product on the market. The Future Fund participated in the second tranche of the fundraising alongside other investors, unlocking matched financing and helping to drive the business forward towards commercialisation.

article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. But what does it take to implement these innovations? Mark holds a PhD in biomedicine, and an MSc in biostatistics.

article thumbnail

LSX Inv€$tival Showcase round-up

pharmaphorum

This proved highly beneficial for those pitching products, mechanisms of action, and companies to investors, allowing them to focus on their presentations, instead of competing to cut through the chatter rising from the floor. How healthcare innovators are weathering market conditions.